Overview

Relative Potency of Inhaled Corticosteroids

Status:
Completed

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

To investigate the validity of a clinical model to determine the relative potency of different preparations of inhaled corticosteroids used for the treatment of asthma or of eosinophilic bronchitis without asthma.

Phase:

Phase 4

Details

Lead Sponsor:

St. Joseph's Healthcare Hamilton

Collaborator:

GlaxoSmithKline

Treatments:

Fluticasone